article thumbnail

Oregon’s Synthetic Cannabinoid Ban Will Protect Consumer Health and Safety

Veriheal

It’s bad news for producers and retailers who jumped on the delta-8 THC bandwagon since this psychoactive substance is included in the list of banned synthetic cannabinoids in Oregon. Because of this, synthetic cannabinoids in Oregon pose a risk to consumer health and safety. state to outlaw sales of synthetic cannabis products.

article thumbnail

Maine’s Cannabis Retailers Break Record, Sell $5.36 Million in May

Cannabis Law Report

AUGUSTA – Maine’s marijuana retailers sold approximately $5.36 Coming in $1 million above the previous record-breaking month of April, retailers conducted 71,843 transactions in May, with smokable marijuana making up 59 percent of sales, while infused products and concentrates accounted for 23 percent and 18 percent, respectively.

Retail 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Rep. Ford introduces Consumable Hemp Licensing bill

Illinois News Joint

In addition, HB4161 would: Permit the wholesale and retail sale of cannabinoids, hemp concentrate, or any other intermediate hemp cannabinoid products. Provide that hemp farms may not create hemp extractions without a processor license. Provide that hemp farms may not engage in retail sales without a hemp retailer license.

Hemp 88
article thumbnail

Don’t let the Grinch stop marijuana reform

NORML

Last Wednesday, he essentially demanded that in exchange for allowing the cannabis industry to access to basic banking services, that the federal government should impose a 2% THC cap on marijuana products and prohibit the retail sale of marijuana-infused edibles or e-liquid vapor extracts.

Banking 225
article thumbnail

US Hemp Roundtable: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results. The methods for both phases were the same.

Safety 52
article thumbnail

CRN Denounces FDA Rejection of New Dietary Ingredient Notifications for Hemp Extract Containing CBD, Urges Congress to Act

Cannabis Law Report

The following is a statement from CRN President & CEO Steve Mister: “CRN is extremely disappointed to learn that FDA rejected NDI notifications for full-spectrum hemp extract containing CBD submitted earlier this year by supplement manufacturers Charlotte’s Web and Irwin Naturals. Congress must take action now.”. Kendall Ridley.

article thumbnail

US Hemp Round Table: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The second cohort included an additional 222 individuals taking CBD produced by an additional five companies.

Safety 52